Transforming growth factor beta 1 expression in human colorectal tumours: an independent prognostic marker in a subgroup of poor prognosis patients.
AffiliationTumour Biochemistry Department, Christie Hospital NHS Trust, Manchester, UK.
MetadataShow full item record
AbstractMembers of the transforming growth factor beta (TGF-beta family, in particular TGF-beta 1, are some of the most potent inhibitory growth factors in a variety of cell types. Resistance to TGF-beta 1-induced growth inhibition is frequently observed in colorectal carcinomas and is associated with tumour progression. Perturbations of TGF-beta 1 expression and function, therefore, may contribute to the loss of some constraints on tumour cell growth. In this study we have examined the expression of TGF-beta 1 and its precursor latency-associated peptide (LAP)-TGF-beta in human colorectal tumours using immunohistochemical techniques. In 86% of the tumours the LAP-TGF-beta complex was present in both the stromal and epithelial cells, whereas the mature TGF-beta 1 peptide was expressed in the glandular epithelium of 58.3% of these tumours. Intense staining for TGF-beta 1 was positively associated with advanced Dukes' stage. Furthermore, there was a significant correlation between the presence of TGF-beta 1 in the tumours and a shorter post-operative survival. This was most significant in a subgroup of patients who had received only a palliative operation. These results suggest that TGF-beta 1 expression may be useful as an independent prognostic indicator for a subgroup of patients who have a particularly poor prognosis.
CitationTransforming growth factor beta 1 expression in human colorectal tumours: an independent prognostic marker in a subgroup of poor prognosis patients. 1996, 74 (5):753-8 Br. J. Cancer
JournalBritish Journal of Cancer
- Significance of transforming growth factor beta1 as a new tumor marker for colorectal cancer.
- Authors: Narai S, Watanabe M, Hasegawa H, Nishibori H, Endo T, Kubota T, Kitajima M
- Issue date: 2002 Feb 1
- Localization of transforming growth factor-beta 1 precursor and latent TGF-beta 1 binding protein in colorectal adenomas.
- Authors: Van Laethem JL, Resibois A, Adler M, Peny MO, Ohtani H, Robberecht P
- Issue date: 1996 Sep
- High levels of transforming growth factor beta 1 in patients with colorectal cancer: association with disease progression.
- Authors: Tsushima H, Kawata S, Tamura S, Ito N, Shirai Y, Kiso S, Imai Y, Shimomukai H, Nomura Y, Matsuda Y, Matsuzawa Y
- Issue date: 1996 Feb
- Expression and role of thrombospondin-1 in colorectal cancer.
- Authors: Miyanaga K, Kato Y, Nakamura T, Matsumura M, Amaya H, Horiuchi T, Chiba Y, Tanaka K
- Issue date: 2002 Nov-Dec
- TGFBI protein high expression predicts poor prognosis in colorectal cancer patients.
- Authors: Zhu J, Chen X, Liao Z, He C, Hu X
- Issue date: 2015